NICE changes mind and backs new drug for severe asthma | Nursing Times
CINQAIR® (reslizumab) Injection – About Asthma Control
Summary of ongoing reslizumab studies in patients with eosinophilic asthma. | Download Table
Brand name: Auvi-Q
Reslizumab | Teva UK
Teva Reports Two Successful Phase III Studies For Reslizumab In Asthma
Reslizumab
FDA approves Teva's Cinqair (reslizumab) Injection
Teva Announces Biologics License Application FDA Acceptance of Reslizumab For Asthma
Older Patients with Asthma Do Well with Reslizumab | RT
Rx Item-Cinqair (Reslizumab) 10Mg/Ml Inj Sinle Use Vial 10Ml By Teva Respiratory
Teva files MAA for asthma treatment reslizumab
Dosing and Administration
Teva-Handok wins approval for anti-asthma injection < Pharma < Article - KBR
Reslizumab Overview - Creative Biolabs
TA479 Review decision paper
Attachment: Product Information: Reslizumab
Teva Announces EMA Validation of Reslizumab Marketing Authorization Application
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
Reslizumab | New Drug Approvals
Teva's Severe Asthma Therapy Reslizumab Now Approved in Europe | RT
Cinqair (reslizumab): Basics, Side Effects & Reviews
